Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7405 p710
17 June 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Nottingham top school in Times guide

Nottingham university's school of pharmacy has been ranked ahead of other UK schools of pharmacy in ‘The Times good university guide 2007’, published last week.

The guide ranks universities by institution and by subject. The subject tables give an overall score, which combines results for research quality, entry standards and the proportion of graduates in “graduate” jobs or further study. Not all universities with schools of pharmacy are ranked in the pharmacy and pharmacology subject tables, including new schools of pharmacy which do not yet have any graduates.

The University of Nottingham was given an overall score for pharmacy and pharmacology of 97.7. The University of Cambridge topped the list in the field of pharmacology with a score of 100. The University of Bath was in third place with an overall score of 96.9 and the University of Manchester was fourth, with a score of 94.7. The lowest performing university listed for pharmacy was Liverpool John Moore’s, with a score of 77.3.

Saul Tendler, head of the Nottingham school, commented: “We are extremely proud to have been recognised in this way … and I am delighted for our staff and students. This has already been an excellent year for pharmacy at Nottingham. We have been awarded £2.5m by AstraZeneca and the Engineering and Physical Sciences Research Council. The grant is funding a new centre of excellence in ‘targeted therapeutics’. This is the first such doctoral training centre to be established in direct collaboration with an industry partner, and aims to train 25 of the most promising PhD students over the next five years.”

Professor Tendler added that the university hoped these students would become future leaders in the pharmaceutical sciences. “It is gratifying now to be declared current leader in pharmacy teaching and research,” he said.

Back to Top


©The Pharmaceutical Journal